The ADCK5 Knockout HAP1 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout population targeting the human ADCK5 gene in the near-haploid HAP1 cell line. Generated by CRISPR/Cas9-mediated disruption of the ADCK5 locus, this polyclonal pool serves as a versatile loss-of-function model for studying coenzyme Q (CoQ) biosynthesis and mitochondrial function. The heterogeneous knockout population is well-suited for pooled screening approaches and essentiality studies in a quasi-haploid background, enabling researchers to probe consequences on ubiquinone production and oxidative phosphorylation without diploid gene dosage effects.
HAP1 is a near-haploid human cell line derived from KBM-7 chronic myeloid leukemia cells, with a stable haploid karyotype. This haploid configuration uniquely allows unambiguous genotype-phenotype correlations, as a single gene disruption yields a null phenotype. Widely adopted for CRISPR-based functional genomics, HAP1 cells facilitate large-scale knockout screens and mechanistic gene function studies. Their robust growth and compatibility with high-throughput assays make them ideal for generating knockout models like the ADCK5 polyclonal population.
ADCK5 is a mitochondrial kinase critical for coenzyme Q biosynthesis. It directly phosphorylates downstream enzymes COQ5 and COQ7, regulating the CoQ biosynthesis complex on the inner mitochondrial membrane. ADCK5 interacts with the COQ protein complex, ADCK family members (e.g., ADCK3, ADCK4), and other pathway components like COQ2, COQ3, COQ9, and COQ10A. Upstream transcriptional regulators PGC-1??, NRF1, and TFAM drive its expression, linking mitochondrial biogenesis to CoQ production. Through these interactions, ADCK5 ensures proper electron transport chain function by maintaining ubiquinone levels.
In HAP1 cells, ADCK5 knockout is particularly informative due to the haploid background, which amplifies phenotypic consequences of gene disruption. Loss of ADCK5 is predicted to impair CoQ biosynthesis, leading to oxidative phosphorylation defects and altered bioenergetics. This model recapitulates aspects of human CoQ deficiency disorders, including mitochondrial dysfunction and potential nephrotic syndrome, offering a tractable platform for disease dissection. The polyclonal nature avoids clonal artifacts, useful for studying heterogeneous loss-of-function effects.
Researchers can employ these ADCK5 knockout HAP1 polyclonal cells in diverse experimental workflows. Applications include mechanistic studies of CoQ biosynthesis, functional validation of interacting partners, and phenotypic screening for mitochondrial respiration modulators. Compatible assays include CoQ10 quantification by HPLC, Seahorse respirometry for oxygen consumption rates, ATP level measurement, and complementation experiments with exogenous ADCK5 expression. The haploid background also enables genome-wide CRISPR screens to identify synthetic lethal interactions or drug targets for CoQ deficiency syndromes. For additional information, please contact Ascent Research.
